Advocates and Lawmakers Call for Changes to Medicare’s Coverage of Alzheimer’s Treatments
More than 6 million Americans are living with Alzheimer’s disease. Despite recent FDA approval, new Alzheimer’s treatments- which experts say that can slow the progression of the disease- are not accessible to many Americans.
